Platelet Aggregation Devices Market - By Product Type (Systems, Reagents, Consumables & Accessories), Application (Research, Clinical [Cardiovascular, Orthopedic]), End-use (Hospitals, Diagnostic Labs, Research Institutes) – Global Forecast, 2024 – 2032

Platelet Aggregation Devices Market Size

Platelet Aggregation Devices Market size was valued at around USD 653.3 million in 2023 and is estimated to grow at over 8.9% CAGR from 2024 to 2032. The rising incidence of chronic diseases and cardiovascular disorders is expected to drive significant growth in the market.
 

The increasing prevalence of chronic diseases is attributed to be the primary driving factor behind the market expansion. Factors such as poor health behaviors, genetic predisposition, aging population, and obesity contributes to this trend. For example, chronic conditions like heart diseases and cancers are leading causes of mortality and morbidity in the U.S., as reported by the Centers for Disease Control and Prevention (CDC).
 

Furthermore, in New York State, over 40% of adults suffer from chronic diseases, which account for 23% of all hospitalizations. Consequently, the rising burden of chronic diseases is anticipated to significantly boost the demand for diagnostic tools such as platelet aggregation devices.
 

Platelet aggregation devices are medical instruments or systems used to assess the ability of blood platelets (a type of blood cell involved in clotting) to clump together and form clots. These devices are primarily utilized in clinical settings to diagnose and monitor various conditions related to blood clotting disorders, cardiovascular diseases, and the effectiveness of antiplatelet medications.
 

Platelet Aggregation Devices Market Trends

Technological advancements are facilitating the incorporation of favourable features into platelet aggregation devices, enhancing their efficiency, and delivering superior outcomes.
 

• Many manufacturers are leveraging cutting-edge technology to develop advanced features in platelet aggregation devices, aiming for more efficient outcomes. For example, companies like Siemens Healthineers are offering integrated systems that merge platelet aggregation testing with routine coagulation analyzers. This integration makes the testing process more manageable, reliable, and accessible to laboratories of various sizes.
   
• These innovative systems address the need for alternatives to traditional platelet aggregation testing, offering solutions that are less complex, easier to incorporate into daily workflows, and require less specialized training for laboratory technicians. Manufacturers' strategic use of technology to enhance platelet aggregation devices is anticipated as the significant driver for market progress.
   
• Additionally, the improvement in reagents and consumables are driving the demand for platelet aggregation devices. The development of new reagents and consumables, such as the Innovance PFA-200 system and the Plateletworks assay, which is a cartridge-based system that measures platelet function under high shear conditions.
   
• These systems have been shown to be more sensitive and specific than traditional platelet function tests and improve the accuracy and reliability of platelet function testing, anticipated to result in the growing demand for platelet aggregation devices.
   

Platelet Aggregation Devices Market Analysis

Based on product type, the market is segmented into systems, reagents, and consumables and accessories. The systems segment held leading revenue share in 2023 and is anticipated to reach USD 688.3 million by 2032.
 

• As the global incidence of cardiovascular diseases continues to rise, there is a corresponding increase in the demand for platelet aggregation systems. These devices are instrumental in diagnosing and monitoring conditions such as arterial thrombosis, a major contributor to cardiovascular events such as heart attacks and strokes. With an aging population and the escalating prevalence of cardiovascular diseases, the demand for platelet aggregation devices is expected to continue its upward trajectory.
   
• Moreover, the capability of platelet aggregation systems to assess individual patients' platelet function profile empowers clinicians to tailor personalized treatment strategies. This advantage has brought significant attention from health professionals, driving the demand for personalized medicine. Consequently, there is a growing market demand for advanced diagnostic tools such as platelet aggregation systems, further fueling the segment expansion.
   

The platelet aggregation devices market by application is categorized into research application and clinical application. The clinical application segment dominates the market with a revenue of around USD 400.9 million in 2023.
 

• With the aging global population, there is a higher prevalence of age-related conditions, including cardiovascular diseases and other disorders affecting platelet function. As the elderly population grows, the demand for platelet aggregation devices for clinical applications is expected to increase.  
   
• Moreover, there is a growing trend towards point-of-care testing in clinical settings, which allows for rapid and convenient diagnostic testing at the bedside or in outpatient settings. Platelet aggregation devices are increasingly being used in point-of-care settings to assess patients' platelet function quickly and accurately, thus, driving growth in the clinical applications.

The platelet aggregation devices market by end-use is categorized into hospitals, diagnostic laboratories, research and academic institutes, and other end users. The hospitals segment dominates the market with a revenue of over USD 303.6 million in 2023.
 

• Hospitals provide comprehensive healthcare services, including emergency care, surgery, and specialized treatments for complex medical conditions. Platelet aggregation devices are essential diagnostic tools in hospital laboratories, enabling clinicians to make timely and accurate diagnoses and treatment decisions for patients with thrombotic and hemostatic disorders, results in the increasing need for these devices in hospitals. 
   
• Moreover, as the population ages, individuals become more susceptible to various health conditions such as diabetes, cardiovascular diseases, and orthopedic conditions. Consequently, there is a notable increase in the number of patients seeking treatment or visiting hospitals for care.
   
• This increased patient load in hospitals underscores the importance of incorporating advanced diagnostic tools like platelet aggregation devices. Therefore, hospitals emerge as the most prominent end users of platelet aggregation devices, as they strive to meet the growing healthcare needs of an aging population.

North America platelet aggregation devices market accounted for USD 229.4 million revenue in 2023 and is predicted to witness substantial market growth.
 

• In North America, the manufacturers of platelet aggregation devices often engage in strategic collaborations and partnerships with healthcare institutions, research organizations, and academic centers. These collaborations facilitate research and development efforts, expand market presence, and drive the adoption of platelet aggregation devices in the region.
   
• Furthermore, North America has well-established healthcare reimbursement systems that often cover the costs associated with diagnostic testing, including platelet aggregation testing. Favorable reimbursement policies encourage healthcare providers to invest in advanced diagnostic tools including platelet aggregation devices, thereby driving the market demand.
   

Platelet Aggregation Devices Market Share

The platelet aggregation devices industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced product based on different technologies is among a key market strategy. Some of the leading industry players including AggreDyne, Inc., Bio/Data Corporation, Chrono-Log Corporation, Siemens Healthineers AG, F. Hoffmann-La Roche Ltd., and Sienco, Inc. among others have a notable presence in the market.
 

Platelet Aggregation Devices Market Companies

Some of the eminent market participants operating in the platelet aggregation devices industry include:

• AggreDyne, Inc.
• Bio/Data Corporation
• Chrono-Log Corporation
• Drucker Diagnostics
• F. Hoffmann-La Roche Ltd.
• Haemonetics Corporation
• Helena Laboratories Corporation
• Siemens Healthineers AG
• Sienco, Inc.
• Sysmex Corporation
• Werfen
   

Platelet Aggregation Devices Industry News

• In January 2021, Haemonetics Corporation welcomed the new guidance issued by the U.S. Food and Drug Administration (FDA) related to the use of viscoelastic testing during the COVID-19 pandemic. This strategic development allowed the healthcare professionals to begin using TEG products for improved patient care during the pandemic. This initiative improved the company’s positioning in the market and enabled more customer base.
   

Platelet aggregation devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Systems
• Reagents
• Consumables and accessories

Market, By Application

• Research applications
• Clinical applications
  • Cardiovascular applications
  • Orthopedic applications
  • Other clinical applications

Market, By End-use

• Hospitals
• Diagnostic laboratories
• Research and academic institutes
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa